Glaxo-Pfizer HIV Drug Helps Hard-to-Treat Patients

Glaxo-Pfizer HIV Drug Helps Hard-to-Treat Patients

Filed under: drug treatment news 2012

An experimental treatment for HIV developed by GlaxoSmithKline Plc (GSK), Pfizer Inc. (PFE) and Shionogi & Co. (4507) reduced the virus in hard-to-treat patients in a late-stage study, providing further support for a regulatory filing by the end of …
Read more on Bloomberg

Tranzyme slips further after lead drug failure

Filed under: drug treatment news 2012

However this is the second time in 2012 that the company's top experimental drug has failed in clinical testing. In March, Tranzyme said it was stopping research on a drug called ulimorelin. The company is running other studies of TZP-102 as a …
Read more on Equities.com

Treatment for Older Glioblastoma Patients Studied

Filed under: drug treatment news 2012

A study designed to evaluate treatment options for older patients (aged ?60 years) with glioblastoma (GBM) has revealed that chemotherapy with temozolomide (Temodar, Merck) or hypofractionated radiotherapy are both more effective than standard …
Read more on Clinical Oncology News

Officials: Prescription drug abuse on the rise in Iowa

Filed under: drug treatment news 2012

“The increased deaths is very concerning, and this is a very serious matter no matter how you frame it,” said Rob Metzger, treatment and services manager for 2nd Judicial District Department of Corrections. According to the State of Iowa Office of Drug …
Read more on UI The Daily Iowan